Joe Rogan Experience #1964 - Rick Doblin

Rick Doblin, Ph.D., is the Founder in 1986 and President of the Multidisciplinary Association for Psychedelic Studies (MAPS), a nonprofit that wholly owns its pharmaceutical arm, MAPS Public Benefit Corporation (PBC), which has completed two highly successful Phase 3 studies of MDMA-assisted therapy for PTSD. MAPS PBC stands at a crossroads between obtaining the additional resources it needs from philanthropy, ensuring public benefit is foremost, or becoming a publicly traded company. maps.org

Rick DoblinguestJoe Roganhost

Jun 27, 20242h 49mWatch on YouTube ↗

EPISODE INFO

Released: June 27, 2024
Duration: 2h 49m
Channel: The Joe Rogan Experience
Watch on YouTube: ▶ Open ↗

EPISODE DESCRIPTION

Rick Doblin, Ph.D., is the Founder in 1986 and President of the Multidisciplinary Association for Psychedelic Studies (MAPS), a nonprofit that wholly owns its pharmaceutical arm, MAPS Public Benefit Corporation (PBC), which has completed two highly successful Phase 3 studies of MDMA-assisted therapy for PTSD. MAPS PBC stands at a crossroads between obtaining the additional resources it needs from philanthropy, ensuring public benefit is foremost, or becoming a publicly traded company. maps.org

SPEAKERS

Narrator
other
Rick Doblin
guest
Joe Rogan
host

EPISODE SUMMARY

In this episode of The Joe Rogan Experience, featuring Narrator and Rick Doblin, Joe Rogan Experience #1964 - Rick Doblin explores rick Doblin and Joe Rogan on Healing Trauma With Psychedelics Rick Doblin, founder of MAPS, joins Joe Rogan to discuss the decades‑long effort to legitimize psychedelic‑assisted therapy, especially MDMA for PTSD and ibogaine for addiction. They trace Doblin’s journey from draft resister and underground psychedelic advocate to leading FDA‑level clinical trials and building bipartisan support, particularly through work with veterans. The conversation explores powerful personal psychedelic experiences (DMT, 5‑MeO‑DMT, ibogaine), neuroplasticity, and how these medicines can disrupt rigid psychological patterns and reduce trauma. They also examine propaganda, media distortions about drugs, the failures of the drug war, and the ethical crossroads MAPS faces as it considers philanthropy versus going public to fund final approvals and global access.

RELATED EPISODES